BIIB vs GTBIF · P/E 21, rev $9.89B vs P/E 31, rev $311.1M
Biogen Inc (BIIB) versus Green Thumb Industries Inc (GTBIF) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Green Thumb Industries Inc (GTBIF) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported GTBIF revenue for 2025-12-31 was $311.1M. Net income was $83.2M. Revenue was up 6.8% from 2025-09-30 to 2025-12-31. GTBIF currently screens at market cap $1.57B and trailing P/E 31.2.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. GTBIF currently screens at market cap $1.57B and trailing P/E 31.2.
Not investment advice. Open the BIIB and GTBIF stock pages for the full models.
Not investment advice.